Artrya Limited

As of June 30, 2026, ARTRYA LTD carries a market capitalization of 359.61M, placing it among publicly traded companies globally. Its enterprise value stands at 308.45M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

ARTRYA LTD's next confirmed earnings release is scheduled for March 2, 2027.

As of June 30, 2026, ARTRYA LTD has 162.96M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 16,895.42, and the price-to-book ratio stands at 6.64.

These figures are as of June 30, 2026. The EV/Sales ratio of 15,918.01 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 308.45M versus a market cap of 359.61M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, ARTRYA LTD maintains a current ratio of 15.72, meaning it holds 15.7x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, ARTRYA LTD posted a negative return on equity (ROE) of -50.58, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -46.20, reflecting losses generated across the asset base.

Over the twelve months ended June 30, 2026, ARTRYA LTD recorded 692.04 in income tax expense. The company reported a pretax loss of -17.43M and -17.43M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended June 30, 2026, ARTRYA LTD generated 19,377.16 in revenue and converted that into -17.43M in net income, yielding earnings per share of -0.12. EBITDA reached -22.13M, while operating income came in at -23.00M.

As of June 30, 2026, ARTRYA LTD holds 51.33M in cash and equivalents against 170,934.26 in total debt, resulting in a net debt position of -30.47M. Total book value stands at 54.18M, with working capital of 51.69M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The operating margin of -118,710.71 and net profit margin of -89,939.29 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Total shareholder yield is negative at -15.20, meaning ARTRYA LTD raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, ARTRYA LTD has an Altman Z-Score of 42.39, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.